Five things for pharma marketers to know: Friday, February 12, 2016

Aegerion slashes workforce; GSK president says downward pressure on drug prices is here to stay; Novartis acquires European rights to Remicade biosimilar

With support of FDA committee, Remicade biosimilar edges closer to market

The FDA is set to announce its decision on the drug in April.

The best and worst celebrity pharma moments

We present to you our picks for the best and worst moments in celebrity healthcare spokespersonship—plus a few more that, frankly, we can't find anywhere.

Drugmakers respond to call for Zika vaccine

Drugmakers respond to call for Zika vaccine

Sanofi is the first to announce the launch of a R&D program for Zika as other pharma companies are assessing whether to join the development race.

What Brand Won the Super Bowl of Pharma?

What Brand Won the Super Bowl of Pharma?

Pharma marketers are wondering if these exorbitant media buys ($4.9 million for 30 seconds) were worth the investment for Valeant and AstraZeneca. Was either strategy successful?

Five things for pharma marketers to know: Thursday, February 11, 2016

Five things for pharma marketers to know: Thursday, February 11, 2016

Copaxone sales fall; Mylan to acquire Swedish drugmaker; health insurers report financial losses from ACA plans

Shannon Hartley, former head of Razorfish Health, joins nonprofit

Shannon Hartley, former head of Razorfish Health, joins nonprofit

She is the first chief marketing officer for Shatterproof.

IPO filing reveals Cannes Lions makes $59 million in annual revenue

IPO filing reveals Cannes Lions makes $59 million in annual revenue

Lions Health, launched in 2014, generated $1.9 million in revenue last year.

Five things for pharma marketers to know: Wednesday, February 10, 2016

Five things for pharma marketers to know: Wednesday, February 10, 2016

SEC is investigating Salix Pharmaceuticals; FDA adcomm recommends approval of Remicade biosimilar; Medicare considers payment changes

Federal agencies and ad groups join forces for prediabetes campaign

Federal agencies and ad groups join forces for prediabetes campaign

The campaign targets 86 million Americans, 90% of whom aren't aware they have the condition.

Five things for pharma marketers to know: Tuesday, February 9, 2016

Five things for pharma marketers to know: Tuesday, February 9, 2016

The FDA to review biosimilar Remicade; lawmaker looks at panelists' ties to painkiller manufacturers; Novartis signs risk-sharing contracts for Entresto

Startup unveils tools to improve trial reproducibility

Startup unveils tools to improve trial reproducibility

The newly launched tools aim to reduce the time and costs of marketing new drugs by "debugging" the lab environment.

New consumer concerns harder for health brands to swallow

New consumer concerns harder for health brands to swallow

Finicky formulary committees and rising consumer cost consciousness add up to a new market dynamic for health brands. A new survey helps break it down.

50 celebrity healthcare endorsements

50 celebrity healthcare endorsements

Here's Jon Bon Jovi for Advil, Arnold Palmer for Xarelto and 48 more past and present celebrity endorsements of drugs, healthcare products and disease awareness campaigns.

Toenail fungus, IBS drugs headline pharma Super Bowl play

Toenail fungus, IBS drugs headline pharma Super Bowl play

It's the industry's biggest turnout in the Super Bowl in three years.

Five things for pharma marketers to know: Monday, February 8, 2016

Five things for pharma marketers to know: Monday, February 8, 2016

PhRMA and BIO ramp up ad spend for presidential election year; Super Bowl Sunday features three pharma ads; Pfizer solidifies leadership team

Taking a Tinder Approach to the Agency-Client Relationship

Taking a Tinder Approach to the Agency-Client Relationship

Imagine if you could choose your agency partners based on attributes most appealing to you. With a swipe to the right or left, you could secure them a roster position or doom them to languish in procurement.

15 unexpected Twitter responses to the "Who Pneu?" campaign

15 unexpected Twitter responses to the "Who Pneu?" campaign

Celebrity success or fail? Here's what the American Lung Association, Pfizer and Tim Daly likely did not see coming when they joined forces to raise awareness about pneumococcal pneumonia.

Agency Spotlight


Email Newsletters